Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits

Molecular Cancer

Volumn 11, Issue , 2012, Pages

  Jaiswal, Ritu ^a,b   Luk, Frederick ^a   Gong, Joyce ^a,b   Mathys, Jean Marie ^c   Grau, Georges Emile R ^b   Bebawy, Mary ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cancer; Microarray; Microparticles; MicroRNA; Multidrug resistance; Selective packaging

Indexed keywords

ABC TRANSPORTER; ARGONAUTE PROTEIN; DICER; FLOPPASE; MEMBRANE ENZYME; MEMBRANE PROTEIN; MICRORNA; MICRORNA 1228; MICRORNA 1246; MICRORNA 1308; MICRORNA 149; MICRORNA 455 3P; MICRORNA 638; MICRORNA 923; PROTEIN DROSHA; SCRAMBLASE; UNCLASSIFIED DRUG;

ARTICLE; BIOGENESIS; CANCER GENETICS; CARCINOGENESIS; CELL COMMUNICATION; CELL STRAIN MCF 7; CELL TRANSFER; CONTROLLED STUDY; DOMINANT INHERITANCE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEMBRANE MICROPARTICLE; MEMBRANE VESICLE; MICROARRAY ANALYSIS; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; RNA STRUCTURE;

BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL-DERIVED MICROPARTICLES; CLUSTER ANALYSIS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; HUMANS; MICRORNAS; NEOPLASMS; QUANTITATIVE TRAIT LOCI;

EID: 84861951099     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-11-37     Document Type: Article

References (66)

1. Gong J, Jaiswal R, Mathys JM, Combes V, Grau GE, Bebawy M. Microparticles and their emerging role in cancer multidrug resistance. Cancer Treat Rev 2011, 12:12.
2. Morel O, Morel N, Jesel L, Freyssinet J-M, Toti F. Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Semin Immunopathol 2011, 33(5):469-486. 10.1007/s00281-010-0239-3, 21866419.
3. Coltel N, Combes V, Wassmer SC, Chimini G, Grau GE. Cell vesiculation and immunopathology: implications in cerebral malaria. Microbes Infect 2006, 8(8):2305-2316. 10.1016/j.micinf.2006.04.006, 16829152.
4. Janowska-Wieczorek A, Marquez-Curtis LA, Wysoczynski M, Ratajczak Mariusz Z. Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion (Paris) 2006, 46(7):1199-1209.
5. van Doormaal FF, Kleinjan A, Di Nisio M, Büller HR, Nieuwland R. Cell-derived microvesicles and cancer. The Netherlands Journal of Medicine 2009, 67(7):266-273.
6. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009, 101(3):439-451.
7. Clark MR. Flippin' lipids. Nat Immunol 2011, 12(5):373-375. 10.1038/ni.2024, 21502987.
8. Hugel B, Martínez MC, Kunzelmann C, Freyssinet J-M. Membrane Microparticles: Two Sides of the Coin. Physiology 2005, 20(1):22-27. 10.1152/physiol.00029.2004, 15653836.
9. Bassé F, Gaffet P, Bienvenüe A. Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation?. Biochim Biophys Acta 1994, 1190(2):217-224. 10.1016/0005-2736(94)90077-9, 8142419.
10. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Curry WT, Carter BS, Krichevsky AM, Breakefield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10(12):1470-1476. 10.1038/ncb1800, 3423894, 19011622.
11. Reich Iii CF, Pisetsky DS. The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. Exp Cell Res 2009, 315(5):760-768. 10.1016/j.yexcr.2008.12.014, 19146850.
12. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9(6):654-659. 10.1038/ncb1596, 17486113.
13. Schetter AJ, Harris CC. Plasma microRNAs: a potential biomarker for colorectal cancer?. Gut 2009, 58(10):1318-1319. 10.1136/gut.2009.176875, 19749133.
14. Lee YM, Cho H-J, Lee SY, Yun SC, Kim JH, Lee SY, Kwon SJ, Choi E, Na MJ, Kang J-K, Son JW. MicroRNA-23a: A Novel Serum Based Diagnostic Biomarker for Lung Adenocarcinoma. Tuberculosis and Respiratory Disease 2011, 71(1):8-14.
15. Ambros V. MicroRNA Pathways in Flies and Worms: Growth, Death, Fat, Stress, and Timing. Cell 2003, 113(6):673-676. 10.1016/S0092-8674(03)00428-8, 12809598.
16. J-i S, Tabunoki H. Comprehensive analysis of human microRNA target networks. BioData Min 2011, 4(1):17. 10.1186/1756-0381-4-17, 3130707, 21682903.
17. Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DSB. Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer. Clin Chem 2011, 57(1):84-91. 10.1373/clinchem.2010.151845, 21036945.
18. Chen G-Q, Zhao Z-W, Zhou H-Y, Liu Y-J, Yang H-J. Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin. Med Oncol 2010, 27(2):406-415. 10.1007/s12032-009-9225-9, 19412672.
19. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009, 10(10):704-714. 10.1038/nrg2634, 3467096, 19763153.
20. Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, Wang NS, Knepper MA. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 2009, 20(2):363-379. 10.1681/ASN.2008040406, 2637050, 19056867.
21. Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola FM, Tucker MA, Bertazzi PA, Pesatori AC, Caporaso NE, McShane LM, Wang E. MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer. Clin Cancer Res 2010, 16(2):430-441. 10.1158/1078-0432.CCR-09-1736, 3163170, 20068076.
22. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu C-G, Kipps TJ, Negrini M, Croce CM. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005, 102(39):13944-13949. 10.1073/pnas.0506654102, 1236577, 16166262.
23. Takeshita F, Patrawala L, Osaki M, Takahashi R-U, Yamamoto Y, Kosaka N, Kawamata M, Kelnar K, Bader AG, Brown D, Ochiya T. Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes. Mol Ther 2009, 18(1):181-187. 2839211, 19738602.
24. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008, 110(1):13-21. 10.1016/j.ygyno.2008.04.033, 18589210.
25. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee M-LT, Schmittgen TD, Nana-Sinkam SP, Jarjoura D, Marsh CB. Detection of microRNA Expression in Human Peripheral Blood Microvesicles. PLoS One 2008, 3(11):e3694. 10.1371/journal.pone.0003694, 2577891, 19002258.
26. El-Hefnawy T, Raja S, Kelly L, Bigbee WL, Kirkwood JM, Luketich JD, Godfrey TE. Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics. Clin Chem 2004, 50(3):564-573. 10.1373/clinchem.2003.028506, 14718398.
27. Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, Rivoltini L. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ 2007, 15(1):80-88.
28. Jung T, Castellana D, Klingbeil P, Cuesta Hernandez I, Vitacolonna M, Orlicky DJ, Roffler SR, Brodt P, Zoller M. CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 2009, 11(10):1093-1105. 2745675, 19794968.
29. Huber V, Fais S, Iero M, Lugini L, Canese P, Squarcina P, Zaccheddu A, Colone M, Arancia G, Gentile M, Seregni E, Valenti R, Ballabio G, Belli F, Leo E, Parmiani G, Rivoltini L. Human Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune Escape. Gastroenterology 2005, 128(7):1796-1804. 10.1053/j.gastro.2005.03.045, 15940614.
30. Al-Nedawi K, Meehan B, Rak J. Microvesicles: Messengers and mediators of tumor progression. Cell Cycle 2009, 8(13):2014-2018. 10.4161/cc.8.13.8988, 19535896.
31. Bussolati B, Deregibus MC, Camussi G. Characterization of molecular and functional alterations of tumor endothelial cells to design anti-angiogenic strategies. Curr Vasc Pharmacol 2010, 8(2):220-232. 10.2174/157016110790887036, 19485921.
32. Bebawy M, Combes V, Lee E, Jaiswal R, Gong J, Bonhoure A, Grau GER. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia 2009, 23(9):1643-1649. 10.1038/leu.2009.76, 19369960.
33. Jaiswal R, Gong J, Sambasivam S, Combes V, Mathys JM, Davey R, Grau GE, Bebawy M. Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J 2011, 30:30.
34. Daleke DL. Phospholipid flippases. J Biol Chem 2007, 282(2):821-825.
35. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 2004, 101(36):13368-13373. 10.1073/pnas.0403453101, 516573, 15326289.
36. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Wurdinger T, Middeldorp JM. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 2010, 107(14):6328-6333. 10.1073/pnas.0914843107, 2851954, 20304794.
37. Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 2009, 11(9):1143-1149. 10.1038/ncb1929, 19684575.
38. Pigati L, Yaddanapudi SCS, Iyengar R, Kim D-J, Hearn SA, Danforth D, Hastings ML, Duelli DM. Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells. PLoS One 2010, 5(10):e13515. 10.1371/journal.pone.0013515, 2958125, 20976003.
39. Wang X. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 2008, 14(6):1012-1017. 10.1261/rna.965408, 2390791, 18426918.
40. Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev 2004, 18(18):2195-2224. 10.1101/gad.1228704, 15371334.
41. Schmitz ML, Mattioli I, Buss H, Kracht M. NF-κB: A Multifaceted Transcription Factor Regulated at Several Levels. ChemBioChem 2004, 5(10):1348-1358. 10.1002/cbic.200400144, 15457532.
42. Suttana W, Mankhetkorn S, Poompimon W, Palagani A, Zhokhov S, Gerlo S, Haegeman G, Berghe W. Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols. Mol Cancer 2010, 9(1):99. 10.1186/1476-4598-9-99, 2873443, 20438634.
43. Wu Q, Lu Z, Li H, Lu J, Guo L, Ge Q. Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnol 2011, 597145:26.
44. Lerebours GC F, Tozlu-Kara S, Vacher S, Lidereau R, Bieche I. MicroRNA Expression Profiling of Inflammatory Breast Cancer. Thirty-Second Annual CTRC-AACR San Antonio Breast Cancer Symposium 2009, Cancer Research 2009: Abstract nr 6118, San Antonio, TX, December 15, 2009.
45. Wang Y, Kelber JA, Cao HST, Cantin GT, Lin R, Wang W, Kaushal S, Bristow JM, Edgington TS, Hoffman RM, Bouvet M, Yates JR, Klemke RL. Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression. Proc Natl Acad Sci 2010, 107(24):10920-10925. 10.1073/pnas.0914776107, 2890752, 20534451.
46. Lin R-J, Lin Y-C, Yu AL. miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol Carcinog 2010, 49(8):719-727.
47. Franke TF. PI3K/Akt: getting it right matters. Oncogene 2008, 27(50):6473-6488. 10.1038/onc.2008.313, 18955974.
48. Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, Kuroda M. Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients. PLoS One 2009, 4(5):e5532. 10.1371/journal.pone.0005532, 2678255, 19440243.
49. Dave RS, Khalili K. Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: Impact on inflammation and oxidative stress in the central nervous system. J Cell Biochem 2010, 110(4):834-845. 10.1002/jcb.22592, 2923828, 20564181.
50. Kahlert C, Klupp F, Brand K, Lasitschka F, Diederichs S, Kirchberg J, Rahbari N, Dutta S, Bork U, Fritzmann J, Reissfelder C, Koch M, Weitz J. Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases. Cancer Sci 2011, 102(10):1799-1807. 10.1111/j.1349-7006.2011.02023.x, 21722265.
51. Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis. Genes Chromosomes Cancer 2009, 48(7):615-623. 10.1002/gcc.20669, 19396864.
52. Broxterman HJ, Gotink KJ, Verheul HMW. Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2009, 12(4):114-126.
53. Fojo T. Multiple paths to a drug resistance phenotype: Mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2007, 10(1):59-67.
54. Zhu H, Chen XP, Luo SF, Guan J, Zhang WG, Zhang BX. Involment of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. J Exp Clin Cancer Res 2005, 24(4):565-574.
55. Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y, Xiong W, Li G, Lu J, Fodstad O, Riker AI, Tan M. MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression. J Biol Chem 2010, 285(28):21496-21507. 10.1074/jbc.M109.083337, 2898411, 20460378.
56. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu C-G, Yang J-M. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008, 76(5):582-588. 10.1016/j.bcp.2008.06.007, 2628586, 18619946.
57. Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, Wagar N, Yoon Y, Cho HT, Scala S, Shim H. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 2010, 79(6):817-824. 10.1016/j.bcp.2009.10.017, 2880168, 19883630.
58. Pogribny IP, Filkowski JN, Tryndyak VP, Golubov A, Shpyleva SI, Kovalchuk O. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int J Cancer 2010, 127(8):1785-1794. 10.1002/ijc.25191, 20099276.
59. Combes V, Coltel N, Alibert M, van Eck M, Raymond C, Juhan-Vague I, Grau GE, Chimini G. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am J Pathol 2005, 166(1):295-302. 10.1016/S0002-9440(10)62253-5, 1602289, 15632021.
60. Kosaka N, Ochiya T. Unraveling the Mystery of Cancer by Secretory microRNA: Horizontal microRNA Transfer between Living Cells. Front Genet 2011, 2(97):3. 3268377, 22303302.
61. Yang M, Chen J, Su F, Yu B, Lin L, Liu Y, Huang JD, Song E. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 2011, 10:117. 3190352, 21939504.
62. Bebawy M, Morris MB, Roufogalis BD. Selective modulation of P-glycoprotein-mediated drug resistance. Br J Cancer 2001, 85(12):1998-2003. 10.1054/bjoc.2001.2184, 2364021, 11747345.
63. Dönmez Y, Akhmetova L, İşeri T, Kars M, Gündüz U. Effect of MDR modulators verapamil and promethazine on gene expression levels ofMDR1andMRP1in doxorubicin-resistant MCF-7 cells. Cancer Chemotherapy and Pharmacology 2011, 67(4):823-828. 10.1007/s00280-010-1385-y, 20563580.
64. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006, 7:3. 10.1186/1471-2199-7-3, 1413964, 16448564.
65. de Hoon MJL, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics 2004, 20(9):1453-1454. 10.1093/bioinformatics/bth078, 14871861.
66. Saldanha AJ. Java Treeview-extensible visualization of microarray data. Bioinformatics 2004, 20(17):3246-3248. 10.1093/bioinformatics/bth349, 15180930.